HR 1266119th CongressIn Committee

Combating Illicit Xylazine Act

Standard Summary
Balanced plain-English summary

The Combating Illicit Xylazine Act aims to control xylazine by adding it to Schedule III of the Controlled Substances Act, defining lawful possession for veterinary purposes, enhancing DEA tracking, and adjusting sentencing guidelines to address its misuse.

Key Points

  • 1Adds xylazine to Schedule III of the Controlled Substances Act to restrict illicit use.
  • 2Defines 'ultimate user' to permit possession for veterinary and animal-control purposes.
  • 3Requires DEA and FDA collaboration on reports assessing xylazine diversion and abuse risks.

Impact Areas

Veterinarians and animal care professionalsDrug Enforcement Administration (DEA)Food and Drug Administration (FDA)Law enforcement and judicial systemsIllicit drug trafficking and public health sectors
Generated by Legislative Analysis AI v3Nov 10, 2025